BioSpace News Archive

The MEDICREA® Group, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ proprietary software platform, services and technologies, announced that it hosted the second edition of its annual Medicrea Artificial Intelligence and Analytics Meeting in New York, NY, USA from April 26-27.

On February 12, 2019, Moberg Pharma entered into an agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest the OTC business for cash consideration of USD 155 million.

New Research about Millennials Shows They Are Less Insured, Less Satisfied, and Visit the Doctor Less

Abstract will be presented at the 2019 American Thoracic Society (ATS) International Conference in Dallas

Egalet Corporation announced that its first quarter 2019 financial results will be released on Thursday, May 16, 2019.

Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on July 22, 2019 to shareholders of record of Quest Diagnostics common stock on July 8, 2019.

Mallinckrodt’s CONFIRM study is evaluating the efficacy and safety of terlipressin in hepatorenal syndrome type 1

VITAS® Healthcare, the nation’s leading provider of end-of-life care, announces the grand opening of the VITAS Healthcare Inpatient Unit (IPU) at Good Samaritan Medical Center.

LifeNet Health, the world’s leading provider of regenerative medicine solutions, today announced the opening of a San Diego facility that stands as a Center of Excellence for its life sciences and tissue-engineering programs, as well as a logistical hub for hospital and surgeon clients on the West Coast.

IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had raised $25 million in Series C funding.